YD Bio Limited Ordinary Shares (YDES) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

Operating IncomeNet Income
02M5M8M10M12M15M18M20MQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Margin (%)

Operating Expenses

Selling General And Administrative Expenses
088K175K262K350K438K525K612K700KQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025

EBITDA

EBITDA
-4M-1M2M5M8M11M14M17M20MQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025

EPS

EPSEPS Diluted
0124568910Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Revenue Variation (%)

Income Variation (%)

Operating Income VariationNet Income Variation
0815223038455260Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Revenue YoY Variation (%)

Income YoY Variation (%)

Price-to-Earning Ratio

P/E Ratio
-6-06111723283440Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Income Breakdown

Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income
06M12M19M25M31M38M44M50MQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Per Share Metrics

Net Income Per ShareOperating Cash Flow Per Share
011223445Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Expense Ratios

💰 Cash Flow Statement

Operating Cash Flow

Free Cash Flow

Cash At End Of Period
025K50K75K100K125K150K175K200KQ2 2024Q4 2024Q1 2025Q2 2025

Cash Flow to Debt Ratio

Net Cash Provided By Operating ActivitiesNet Cash Used Provided By Financing Activities
050K100K150K200K250K300K350K400KQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025
🏦 Balance Sheet
📈 Key Metrics